The relationship between the plasma triglycerides and the LDL triglycerides of 30 normal and 48 hypertriglyceridemic subjects has been quantified; the data fit a simple adsorption isotherm, LDL triglyceride/(LDL triglyceride + LDL cholesterol ester) = 0.65 plasma triglyceride/(464 + plasma triglyceride). In vitro transfer of triglyceride from concentrated VLDL to VLDL-depleted plasma produced triglyceride-rich LDL that had similar properties. LDL uptake by HepG2 cells increased with LDL triglyceride content whereas the reverse was found with skin fibroblasts. At 370C, the cores of both normal and hypertriglyceridemic LDL were isotropic liquids. Circular dichroic spectra revealed no difference in the secondary structure of normal and triglyceride-rich LDL. The affinity of monoclonal antibody MB47, which binds to the receptor ligand of apo B-100 was independent of LDL triglyceride content. MB3, which binds near residue 1022 ofapo B-100, showed a triglyceride-dependent decrease in affinity for LDL from hypertriglyceridemic subjects and from in vitro incubations. LDL with an elevated triglyceride content formed in vitro had reduced proteolytic cleavage of apo B-100 by Staphylococcus aureus V8 protease. From these data, we infer that (a) LDL triglyceride is a predictable function of plasma triglyceride, (b) triglyceride induces subtle changes in apo B-100 structure at a site that is remote from the putative receptor binding ligand, and (c) the triglyceride-dependent receptor-binding determinants of apo B-100 are recognized differently by fibroblasts and HepG2
Introduction
Epidemiological studies have established that premature atherosclerosis is indirectly associated with elevated plasma triglyceride ( 1, 2). Familial hypertriglyceridemia, expressed as several phenotypes, results from an excess of VLDL or chylomicron synthesis. Reduced lipoprotein clearance from the plasma compartment secondary to other disease states, such as diabetes mellitus, chronic renal disease, or obstructive liver dis-ease, also produces hypertriglyceridemia (3) . In vivo the fractional catabolic rate of hypertriglyceridemic LDL in hypertriglyceridemic subjects is faster than that of normal homologous LDL (4) , with the primary site for the clearance of intact LDL particles being located on the surface of liver cells (5) (6) (7) . In spite of the accelerated rate of catabolism, uptake of hypertriglyceridemic LDL in cultured fibroblasts, the most commonly used cell line to model receptor-mediated uptake, is lower than that observed with normal LDL (8) .
The core of LDL is one putative source ofthe lipid deposits in atherosclerotic plaques (9) . The LDL particle consists of a hydrophobic core ofcholesterol, cholesterol ester, and triglyceride, with a surface composed primarily ofamphiphilic phospholipids, cholesterol, and apo B-100, which is the ligand for cell surface receptor-mediated uptake (10-12). Elevated plasma chylomicron and VLDL triglyceride levels increase the triglyceride content of LDL in a process mediated by the action of plasma lipid-transfer proteins ( 13, 14) . This in turn produces changes in the physical properties of the particle surface and core (15) (16) (17) (18) . In this report we describe the effects of elevated plasma triglyceride on the lipid composition and physical properties of LDL from normal and hypertriglyceridemic subjects and its subsequent catabolism by cultured fibroblast and HepG2 cells.
Methods
Materials. After an overnight fast, plasma was obtained by venipuncture from volunteers from the laboratory staff in Houston and from hypertriglyceridemic patients ofthe Lipid Clinic in Innsbruck, Austria. The case-control study population was composed of normolipemic subjects and hypertriglyceridemic subjects with a fasting plasma triglyceride > 250 mg/dl (3, 19) . Informed consent was obtained from all participants. LDL was isolated by sequential and rate zonal ultracentrifugation (20) in the density range 1.019-1.063 g/ml. The homogeneity ofthe isolated LDL was assessed by nondenaturing (2-16%; Pharmacia LKB Biotechnology Inc., Piscataway, NJ) polyacrylamide gradient gel electrophoresis (21 ) . The apoprotein composition of LDL was based on SDS-PAGE on 4-12% gradient gels (22). LDL surface charge was evaluated by their mobility on 1% agarose Universal gels relative to acetylated LDL (Ciba Corning, Palo Alto, CA). Plasma cholesterol, HDL cholesterol, and triglyceride levels were measured using a autoanalyzer (COBAS FARA II; Roche Diagnostics, Montclair, NJ).
LDL triglyceride, total cholesterol, and free cholesterol were determined using enzymatic assay kits from Boehringer Mannheim Diagnostics (Indianapolis, IN) . Cholesterol esters were calculated from the difference between total and free cholesterol, multiplied by 1.65 to correct for the presence of the acyl chain (23) . LDL protein was determined by the Markwell modification of the Lowry protein assay (24) using BSA as a standard. Acetylated LDL was produced by the method of Basu et al. (25) . Transesterification of cholesterol esters isolated by TLC with methanolic BF3 produced methyl esters from which the acyl composition was determined by capillary-column gas liquid chromatography. Fatty acids were identified by comparison of retention times with those of standard mixtures (Nu Check Prep, Inc., Elysian, MN).
Monoclonal antibodies against apo B-I00, MB47, and MB3 were the generous gifts of Dr. Linda Curtiss. Polyclonal anti apo E was obtained through the Baylor College of Medicine Animal Program.
Experimental procedures. In vitro transfer oftriglyceride from concentrated VLDL to LDL was performed as follows: plasma obtained from a unit of fresh normolipidemic blood was mixed with 0.2 U/ml aprotinin, 175 jg/ml PMSF, 50 jig/ml leupeptin, and 5 Ag/ml gentamicin (Sigma Chemical Co., St. Louis, MO). It was then centrifuged at 50C to float the VLDL. The top half of the tube, which included the VLDL and the clear zone beneath it, was removed and discarded. Pooled VLDL from several normolipidemic donors was filtered through a 0.45-Mim filter and concentrated by ultrafiltration at 40C. The VLDL was mixed with the 1.006 bottom fraction and incubated at 370C for varying times and at varying VLDL concentrations equivalent to plasma triglyceride concentrations. Samples were removed after incubation at 370C and transferred to an ice bath. The density of each sample was adjusted to 1.019 g/ml with solid KBr and centrifuged overnight at 35,000 rpm at 50C. The VLDL was removed, and the infranatant was overlaid with a 1.006 g/ml Kbr solution and centrifuged again at 40,000 rpm; the supernatant was discarded. The infranatant was adjusted to a density of 1.063 with solid Kbr and spun overnight. The LDL obtained was analyzed for triglyceride, cholesterol, cholesterol ester, protein, and size by gel electrophoresis. LDL thermotropic transitions were measured with a Microcal MC-2 differential scanning calorimeter (Northampton, MA). The samples (2-21 mg of LDL-protein dialyzed against Tris-buffered saline, 10 mM Tris, 100 mM NaCl, 1 mM EDTA, and 1 mM NaN3, pH 7.4) were scanned three times at 10°C/h. Apo B-100 secondary structure was estimated using a spectropolarimeter (Model J-50OA; Jasco Inc., Tokyo, Japan). LDL (100 ,tg/ml protein) samples dialyzed against 10 mM sodium phosphate pH 7.4 were scanned 10 times from 260 to 184 nm. The averaged scans were baseline corrected, and the relative contributions of alpha helix, beta sheet, beta turn, and random coil were estimated using eigenanalysis and the spectra of peptides of known secondary structure (26) .
LDL binding and uptake by the human hepatoma cell line, HepG2, and by human fetal foreskin fibroblasts was measured according to a modification of the method of Goldstein et al. (27) . Both cell lines were grown in DME supplemented with 10% FBS. Each dish was rinsed with PBS and incubated for 48 h with DME plus 5% lipoproteindeficient serum (LPDS).' Triplicate samples of radioiodinated LDL in 5% LPDS in DME buffered with bicarbonate for uptake studies or DME buffered with Hepes for binding studies, plus a second similar series of samples containing both radiolabeled LDL plus 500 ,g/ml of unlabeled LDL were incubated with the cells. Before use, all LDL samples were passed through a 0.45-tim filter. After incubation the wells were rinsed with three rapid washes of PBS plus 2 mg/ml BSA, followed by two ( 10-min) washes with PBS-BSA and a final wash of PBS alone. The dishes were then incubated with 1 ml of sodium dextran sulfate (4 mg/ml) in 50 mM NaCl, 10mM Hepes, pH 7.4, at 4°C for 1 h. After the dextran sulfate wash was removed and an aliquot was counted to determine cell surface binding, the cells were digested with 1 ml of 0.1 N NaOH. Aliquots were removed for protein analysis and radiolabel uptake by gamma counting. All results were corrected for nonspecific binding of LDL to blank wells.
The relative affinities ofmonoclonal antibodies MB3 and MB47 for LDL apo B-100 were measured by a direct binding assay using a standard ELISA. LDL (500 ng) in standard buffer from each sample was bound to a duplicate series of 12 wells on a 96-well plate overnight at 4°C. After washing the plates four times with 0.25% BSA in PBS and blocking with 3% BSA in PBS for 1 h, serial dilutions of MB3 and MB47 were made for each of the sample wells. The plates were again incubated overnight at 4°C and washed four times the next day with 0.25% BSA in PBS. The horseradish peroxidase conjugate ofgoat anti- Fig. 1 A. The data were fitted to an adsorption isotherm that took the form WR = 0.65 plasma triglyceride/ (464 + plasma triglyceride).
(1)
Saturation of the isotherm occurred at a triglyceride/(neutral lipid) ratio of 0.65. To determine if the above isotherm repre- Functional assays ofnormal and hypertriglycerdemic LDL. The uptake of LDL and hypertriglyceridemic LDL by cell surface receptors was tested in two model systems that were selected because they are representative of the kinds of cells that are found in hepatic and peripheral tissues; these were, respectively, the human hepatoma cell line, HepG2, and human skin fibroblasts derived from the preputial tissue ofnormal subjects. HepG2 cells have been shown to be a suitable model system for the study of hepatocytic lipoprotein metabolism by a number ofauthors (29-3 1 ) . The binding of normal and hypertriglyceridemic LDL was compared (Table III) . The data from the fibroblasts confirmed the observations of Aviram et al. (8), who reported that the uptake of hypertriglyceridemic LDL to fibroblasts was lower than that ofnormal LDL. In contrast, our data with HepG2 cells showed that in this cell line the uptake of hypertriglyceridemic LDL was greater than that of normal LDL. We then selected a subset of four subjects from the clinical data group that had WR ranging from 0.10 to 0.50 and performed LDL receptor saturation studies using HepG2 cells (Fig. 2 A) . The lower curve represents the difference between total LDL uptake and nonspecific uptake by the cells. Receptor uptake increased with amount ofLDL and saturated the receptor at -250 ,ug/ml. LDL with WR = 0.50 and 0.30 were taken up to a greater extent than LDL with WR = 0.19 or 0.10 (Fig. 2 B) .
Native normal and hypertriglyceridemic LDL structures. On the basis of circular dichroic criteria, the secondary structures of normal LDL and hypertriglyceridemic LDL having a range of WR extending from 0.10 to 0.73 was indistinguishable; the calculated secondary structures were alpha-helix (24±5.2%), beta sheet (28±3.9%), beta turn (23±1.1%), and random coil (24±1.7%).
Nondenaturing gradient gel electrophoresis of normal and hypertriglyceridemic LDL usually resulted in two bands corresponding to LDL, and LDL2; however, the hypertriglyceridemic LDL (data not shown) displayed somewhat greater electrophoretic mobility than that from normolipidemic plasma. The liquid crystal to isotropic liquid transitions of 22 normal and 12 hypertriglyceridemic subjects were measured by differential scanning calorimetry.
Melting temperatures were determined from the midpoint of excess heat capacity endotherms (Fig. 3 C) . The average melting temperature of the LDL obtained from the hypertriglyceridemic subjects was -6.50C lower than that ofthe nor- by HepG2 cells at 370C. (Table I) . However, in all cases the melting temperatures were below 370C. The LDL melting temperatures correlated with the plasma triglyceride LDL levels of the donor, with the melting temperatures decreasing as plasma triglyceride increased (Fig. 3 A) . LDL melting temperatures correlated with triglyceride content but were independent of cholesterol ester fatty acyl chain composition. An increase in the WR produced a linear decrease in LDL melting temperature (Fig. 3 B) , as described by the equation The width ofthe transitions increased with increasing triglyceride content and, in some cases of severe hypertriglyceridemia, the endotherms were too broad to permit accurate quantification of the melting temperature. For the 34 subjects that are plotted in Fig. 3 B, the correlation coefficient was -0.68.
Structure and properties of in vitro hypertriglyceridemic LDL. To characterize the structure-function relationships that distinguish the hepatocellular uptake of LDL and hypertriglyceridemic LDL, the latter were formed in vitro by using the lipid transfer activity ofhuman plasma as a mediator oftransport of triglyceride from an excess of VLDL to LDL. Over a 24-h time interval, the WR increased from an initial value of0.10 to 0.56 (Fig. 4 A) for VLDL. The calculated limit ofWR at t = infinity was 0.62. The fivefold change in WR was similar to the range that was observed in the plasma LDL of our sample population. The increase in the triglyceride content of the LDL produced similar effects on the thermotropic behavior of the in vitro hypertriglyceridemic LDL that were observed in the native LDL ofthe sample population. The increase in the triglyceride content was accompanied by a continuous reduction in the transition temperature from 25 to -2.50C, the last value being obtained by extrapolation of the data to 24 h (Fig. 4 A) . No lipolytic activity was present in our in vitro incubations, therefore, the production ofsmall dense LDL particles through the lipolysis oftriglyceride-rich LDL that is observed in vivo in hypertriglyceridemia did not occur. This was verified by nondenaturing gel electrophoresis in which the in vitro hypertriglyceridemic LDL was distributed into two subfractions, LDL, and LDL2, which exhibited the same electrophoretic mobilities as those of their respective counterparts before enrichment with triglyceride. The average particle size was 26.75±0.91 nm. SDS-PAGE analysis of the in vitro hypertriglyceridemic LDL revealed a single band corresponding to that ofapo B-I00; no other protein band was found, even where the gels were greatly overloaded. Immunochemical assays for the presence of apo E were also negative.
With HepG2 cells there was enhanced receptor specific uptake of in vitro hypertriglyceridemic LDL (Fig. 4 B) that increased with the triglyceride content of the particle. This occurred where the particle melting temperature decreased from > 25 to < 00C. Therefore, receptor binding was independent of the physical state of the lipid at 370C, which was that of an isotropic liquid. Similar results were obtained for LDL degradation (data not shown) and in equilibrium binding to the receptor at 40C (Fig. 4 C) . LDL with a tenfold increase in WR (0.05 vs. 0.53) displayed greater saturation binding to the cell surface. The dissociation constants as determined by Scatchard analysis were 21 Ag/ml for the low triglyceride LDL versus 28 ,gg/ml for the hypertriglyceridemic LDL (Fig. 4 D) , while the maximum amount of LDL bound was 32 ng/mg cell protein for low WR LDL versus 37 ng/mg protein for the hypertriglyceridemic LDL.
The association of a monoclonal antibody (MB47) that binds to apo B-100 at a site that inhibits binding to the LDL receptor with in vitro hypertriglyceridemic LDL was measured. Over a wide range of WR, the binding of this antibody was independent of the triglyceride content of the in vitro hypertriglyceridemic LDL (Fig. 5 B) . Similar data (not shown) were obtained for the four subjects whose LDL were used for the receptor uptake experiments.
In contrast, the association of MB3 with apo B-100 varied with the triglyceride content ofthe particle (Fig. 5 C) . Increasing amounts oftriglyceride produced a decreased affinity ofthe antibody for the epitope on apo B-100 surface. The negative correlation between LDL triglyceride and the binding of MB3 to LDL was also found in LDL from the subset of the study population used in the HepG2-uptake experiments (Fig. 5 A) . The lone exception to this correlation may be due to apoprotein heterogeneity (32), however, since the in vitro hypertriglyceridemic LDL was obtained from a single subject, apoprotein heterogeneity may be ruled out as the cause of differential MB3 binding.
In vitro triglyceride-enhanced LDL exhibited increased particle migration on agarose gels. The mobility relative to that of acetylated LDL increased in a time-dependent fashion and nearly doubled as the WR rose from 0.05 to 0.53 (Fig. 6 B) . Incubation times of up to 48 h produce LDL that increase in negative charge but never equal that of acetylated LDL.
Independent verification of triglyceride-induced alteration of apo B-100 tertiary structure was obtained by partial proteolytic digestion of in vitro hypertriglyceridemic LDL by S. aureus V8 protease (Fig. 6 A) . Control LDL samples that were incubated with VLDL very briefly before ultracentrifugation (lanes 1-4) were far more susceptible to proteolytic digestion than those that had been incubated for 24 h (lanes 5-8) . In the hypertriglyceridemic LDL showed very little fragmentation even after 90 min of incubation with the protease. It appears that the exchange ofcholesterol ester for triglyceride produces a change in apo B-100 conformation or accessibility that is independent of LDL particle size.
Discussion
Plasma triglyceride determines LDL core composition and melting properties in a predictable way. Clinical assessment of lipoprotein status typically includes the determination of fasting plasma triglyceride levels. Although no quantitative model was proposed, a logarithmic correlation between LDL triglyceride and fasting triglyceride levels has been reported ( 13 ). Analysis of the correlation between plasma triglyceride and LDL triglyceride content led to a quantitative predictive model (Fig. 1 A, Eq. 1). There is considerable scatter in the data, but this is probably due to transient daily fluctuations in the plasma triglyceride levels (33) and not those ofLDL triglyceride content. Our data were fitted to an adsorption isotherm in which the asymptote corresponds to WR = 0.65 (Fig. 1 A) . Our efforts to duplicate conditions within the plasma compartment in vitro produced an isotherm with a similar saturation WR (0.70) but differing in Kd, 91 versus 464 mg/dl for the cross sectional study (Fig. 1 B, Eq. 2) . In vitro the system was allowed to come to equilibrium, Fig. 1 C demonstrates Figs. 1 A and B should approximate that of VLDL, the major triglyceride pool in fasting plasma. These values are slightly less than that of VLDL, which is typically between 0.6 and 0.9, with an average value being 0.8 (38, 39) . The slight difference between the measured ratio for LDL and the observed value for VLDL may be due to intrinsic differences in the affinities of LDL and VLDL for triglyceride and cholesterol ester (40) .
The calorimetric data correlate with plasma triglyceride levels (Fig. 3 A) and the triglyceride content ofLDL (Figs. 3 B and  4 A) ; the melting temperature decreases with both increasing plasma triglyceride and WR values. This behavior was similar for both native and in vitro LDL. Phase diagrams of triglyceride and cholesterol ester predict that ifthe neutral lipids ofLDL are confined to a common domain, the melting temperature will decrease with increasing triglyceride content (41) . At 370C, the cores of both native and hypertriglyceridemic LDL are in a melted state. Therefore, the differences in the binding of normal LDL and hypertriglyceridemic LDL to cells was not a function of the physical state of the neutral lipid core. Moreover, the intracellular metabolism of the neutral lipids in the LDL of the normal and hypertriglyceridemic subjects should not differ greatly (42, 43) .
Functional alterations of hypertriglyceridemic LDL. Our data (Table III) confirm the previous reports ofreduced uptake of LDL derived from hypertriglyceridemic subjects in fibroblast culture (8, 44) . In contrast, with HepG2 cells there was enhanced uptake of native and in vitro hypertriglyceridemic LDL (Figs. 2 B and 4 B) . There are two reasons for these observed differences. First, there are cell-specific differences in the LDL receptor that are due to either changes in receptor number or modification of the receptor itself. The LDL receptor in hepatocytes, HepG2 cells, and fibroblasts appears to be the same 130-kD protein (45) , however, the HepG2 receptor has a 10-fold higher dissociation constant (-20 vs. 2 ,g/ml) than the skin fibroblasts (46). HepG2 cells also have higher absolute levels of LDL receptor mRNA than fibroblasts, but both cell lines show a similar degree of upregulation in response to LPDS (47) . However, in HepG2 cells the receptor number is differentially increased relative to the receptor number in fibroblasts in response to several stimuli such as taurine, estrogen, and high density lipoproteins, all of which are believed to increase LDL receptor synthesis by depleting the cells of cholesterol (46, 48, 49) . HepG2 cells also respond to a plasma component that stimulates receptor synthesis without a corresponding cellular cholesterol depletion whereas fibroblasts are unresponsive (50) . Morphological data suggests that the hepatocytic receptor differs from that of the fibroblast in that it is diffusely distributed along the sinusoidal microvilli rather than concentrated primarily in coated pits ( 51 ) . This may explain why binding is independent of particle size in HepG2 cells (52) . Recently, Pathak et al. (53) showed in transgenic mice that sorting of LDL receptors to the cell surface is tissue specific and that targeting of the receptor to the hepatocyte basolateral surface is determined by residues 812-828 in the cytoplasmic domain of the receptor (54) . Finally, the LDL receptor protein itself has been shown to exhibit local variation in affinity for LDL (55).
Second, there are structural differences between normal LDL and hypertriglyceridemic LDL that are associated with differential binding to fibroblasts and HepG2 cells. Since it is known that the LDL found in hypertriglyceridemic subjects is smaller than that of normal LDL, size may be a determinant of apo B-100 structure. However, the LDL formed by the in vitro incubation of LDL with excess VLDL in the absence of lipo- (Fig. 4 B) that were seen in LDL isolated from hypertriglyceridemic subjects (Fig. 2 B) . Additionally, the in vitro incubation of VLDL with LDL from a single donor demonstrates that the differential LDL uptake was not the result of apo B-100 polymorphism, which may have occurred in LDL obtained from the case-control study population (32).
There could be differences in the amount of apo E associated with normal and hypertriglyceridemic LDL. However, neither gradient gel electrophoresis nor immunochemical assays detected any increase in apo E content with incubation time. Vega and Grundy (37) found that patients with familial dyslipoproteinemia had high fractional catabolic rates for hypertriglyceridemic LDL, even though they possessed the apo E2/E2 phenotype, which has a low LDL receptor affinity.
The most likely explanation for the differential uptake of normal LDL and hypertriglyceridemic LDL is that increased LDL triglyceride directly affects the tertiary structure or environment ofapo B-100 independent ofthe size ofthe LDL. The triglyceride-induced changes alter apo B-100 affinity toward the LDL receptor, producing increased uptake by HepG2 cells and reduced uptake by fibroblasts. Aviram et al. (8) reported that increased triglyceride content of LDL produced alterations in surface accessibility of apo B-100 lysine residues and decreased fibroblast and macrophage uptake of the particle. This seems the most likely explanation for the increased electrophoretic mobility on agarose gels. Triglyceride-rich LDL shows decreased affinity for the LDL receptor whereas acetylated LDL, in which most of the positively charged lysine residues are derivatized, shows almost no affinity for the fibroblast LDL receptor. Since there was no detectable difference between the circular dichroic spectra of normal and hypertriglyceridemic LDL, the conformational differences must be rather small. Additionally, it must be remembered that both electrophoretic mobility and ellipticity are the result of net particle charge and peptide bond absorption, respectively. Further verification of this phenomenon is seen in studies (56, 57) ofa point mutation in apo B-100 where an arginine at residue 3500 was replaced by a glutamine. The LDL that contain this mutation have reduced accessibility of the lysines and reduced binding to cultured fibroblasts but no spectroscopically detectable alterations in the apo B-100 secondary structure.
Two lines of evidence suggest that the structural difference between normal LDL and hypertriglyceridemic LDL does not involve the putative receptor ligand in a direct way. First, the binding ofMB47 to LDL, which is known to bind apo B-100 at or near its receptor-binding domain, was independent oftriglyceride content. In contrast, the difference in the binding of monoclonal antibody MB3, which binds near residues 1022-1031 (28) to normal and hypertriglyceridemic LDL, suggests that there are functionally important triglyceride-dependent structural changes in a region of apo B-100 that is remote from the highly conserved receptor ligand site (58, 59) , which may in turn alter the affinity of hypertriglyceridemic LDL for the B/E receptor. Second, our data from in vitro production of hypertriglyceridemic LDL suggests that the conformation or accessibility of apo B-100, induced by the substitution oftriglyceride for cholesterol ester, obscures the S. aureus V8 proteolytic site that is close to the binding site of MB3. According to Kunitake et al. (28) , who demonstrated preferential proteolytic cleavage of an apo B-100 fragment in the triglyceride-rich LDL of patients with Tangier disease, this site is located at residue 1076 (Fig. 6) . Although this site may be spatially distant from the putative receptor-binding residues 3345-3381 in the apo B-100 primary structure, it may be near the receptor ligand on the LDL surface topology because of folding of the protein (60, 61 ) .
Metabolism ofnormolipidemic LDL and hypertriglyceridemic LDL. The differences in the regulation and structure ofthe B/E receptors of cells of hepatic and nonhepatic origin are important to our understanding of how triglyceride content regulates LDL turnover. Our data quantifies the expected rise in LDL triglyceride with plasma triglyceride levels, and the major functional effect of the change in LDL composition is a subtle change in the structure or accessibility of a region of the LDL remote from the receptor region. If HepG2 cells are a suitable model for the uptake of LDL by the liver, the major site for the turnover of LDL in humans, one would expect the rate ofturnover ofhypertriglyceridemic LDL to be greater than that of normal LDL. In support ofthis, Vega and Grundy (37) reported that the turnover of hypertriglyceridemic LDL is 22% faster than that of normal LDL. In this context it seems likely that if peripheral tissue, for which fibroblasts are a model, were ofimportance, the LDL turnover rates would be slower. In fact, if there is less uptake by peripheral tissue in vivo, the actual increase in uptake by liver would exceed even the observed value of22%. This information should be useful in understanding how diet and drugs alter LDL catabolism. Additional turnover data in humans or suitable animal models should demonstrate the relative importance of hepatic and nonhepatic tissue in LDL catabolism in hypertriglyceridemic subjects.
